Biennially, the Foundation bestows the Charles Rodolphe Brupbacher Prize for Cancer Research upon a scientist who has made extraordinary contributions to basic oncological research.
The Prize ceremony takes place within the framework of a Scientific Symposium, which includes the Charles Rodolphe Brupbacher Public Lecture.
 |
|
| Award ceremony 2013 from left: lic. jur., LL.M., Georg Umbricht (Member of the Foundation Board), Dr. Michael Karin, Dr. Klaus Grätz (Dean of the Medical Faculty) |
|
| Laureates |
|
 |
 |
| 2013 | |
 |
 |
| Prof. Dr. Michael Karin Department of Pharmacology University of San Diego La Jolla, California, USA |
Inflammation and Cancer: Effects, Mechanisms and Therapeutic Implications (pdf) |
|
|
| 2011 | |
|
|
| Prof. Dr. Bert Vogelstein Howard Hughes Medical Institute The Johns Hopkins University Baltimore, Maryland, USA |
The genetic basis of human cancer and its implications for patient management (pdf) |
| Prof. Dr. Jan H. Hoeijmakers Department of Genetics Erasmus Medical Center, Erasmus University Rotterdam, The Netherlands |
DNA damage and its impact on cancer, aging and longevity (pdf) |
|
|
| 2009 | |
|
|
| Dr. Nubia Muñoz International Agency for Research on Cancer (IARC) Emeritus Scientist Lyon, France |
From causality to prevention: The case of cervial cancer (pdf) |
| Prof. Sir Richard Peto Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU), University of Oxford Oxford, United Kingdom |
The absolute benefits of anti-cancer drugs and of tobacco control (pdf) |
|
|
| 2007 | |
|
|
| Prof. Dr. Lloyd J. Old Ludwig Institute for Cancer Research New York, USA |
Contributions to the Field of Cancer Immunology (pdf) |
| Prof. Dr. Robert D. Schreiber Department of Pathology and Immunology, Washington University, School of Medicine St. Louis, Missouri, USA |
Cancer Immunoediting: Deciphering the Complex Interaction Between Immunity and Developing Tumors (pdf) |
| Prof. Dr. Mark J. Smyth Cancer Immunology Program Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia |
Extrinsic tumor suppression by innate and adaptive immunity (pdf) |
|
|
| 2005 | |
|
|
| Prof. Dr. Mariano Barbacid Centro Nacional de Investigaciones Oncologicas Madrid, Spain |
The Molecular Bases of Human Cancer: a 25 Year Journey |
| Prof. Dr. Klaus Rajewsky The CBR Institute for Biomedical Research Harvard Medical School Boston, MA, USA |
The Janus Face of Antibody Formation: Protective Function and Tumor Risk |
|
|
| 2003 | |
|
|
| Prof. Dr. Rudolf Jaenisch Whitehead Institute for Biomedical Research, MIT Cambridge, MA, USA |
Nuclear Cloning and the Reversibility of Cancer |
| Prof. Dr. Erwin Wagner Institute of Molecular Pathology Vienna, Austria |
Unravelling the Functions of AP-1 (Fos/Jun) in Mouse Development and Disease |
|
|
| 2001 | |
|
|
| Prof. Dr. Brian Druker Oregon Health Sciences University Portland, Oregon, USA |
Clinical and Basic Oncology: New Developments |
|
|
| 1999 | |
|
|
| Prof. Dr. George Klein Microbiology and Tumor Biology Center (MTC) Karolinska Institute Stockholm, Sweden |
Cancer and the New Biology |
| Prof. Dr. Harald zur Hausen Deutsches Krebsforschungzentrum Heidelberg, Germany |
Cancer Causation by Viruses |
|
|
| 1997 | |
|
|
| Prof. Dr. Laurent Degos Institut Universitaire d'Hématologie Hôpital Saint Louis Paris, France |
Differentiation Therapy of Cancer |
| Prof. Dr. Zhen-yi Wang Shanghai Institute of Hematology Rui-Jin Hospital Shanghai Second Medical University Shanghai, PR China |
Treatment of Acute Promyelocytic Leukemia with All-Trans Retinoic Acid: A Model of Differential Therapy in Cancer |
|
|
| 1995 | |
|
|
| Prof. Dr. Alfred G. Knudson Fox Chase Cancer Center Philadelphia, PA, USA |
Hereditary Cancer |
| Prof. Dr. Robert A. Weinberg Whitehead Institute for Biomedical Research, Rui-Jin Hospital Department of Biology, MIT Cambridge, MA, USA |
Genes and Cancer |
|
|
| 1993 | |
|
|
| Prof. Dr. Arnold J. Levine Department of Molecular Biology Lewis Thomas Laboratory Princeton University Princeton, N.J., USA |
Functions of the p53 Gene and Protein |
| Prof. Dr. David P. Lane Cancer Research Campaign Laboratories Department of Biochemistry University of Dundee Dundee, Scotland |
The p53 Pathway, Past and Future |
|
|